Andere Sprachen PROCEPT BioRobotics Corporation

Aktien

A3C3AJ

US74276L1052

PRCT

Markt geschlossen - Nasdaq Andere Börsenplätze 21:59:49 29.05.2024			% 5 Tage	% 1. Jan.
64.01 ^USD	-0.73%		-4.55%	+52.73%

15.05.	Transcript : PROCEPT BioRobotics Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM
06.05.	PROCEPT BIOROBOTICS CORPORATION : Bewertung von Piper Sandler zum Kaufen erhalten	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PROCEPT BioRobotics : Leerink Partners Healthcare Crossroads Conference 2024	29.05.
PROCEPT BioRobotics : AUA 2024 Investor Presentation	23.05.
PROCEPT BioRobotics : 2024 Bank of America Heathcare Conf	15.05.
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference	13.05.
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia	06.05.
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia	06.05.
PROCEPT BioRobotics Corporation Announces Long-Term, Real-World Data Showing the Benefits of Aquablation Therapy for the Treatment of Symptomatic Prostatic Hyperplasia	06.05.
Procept BioRobotics Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing	06.05.
Procept BioRobotics Insider Sold Shares Worth $1,916,428, According to a Recent SEC Filing	06.05.
PROCEPT BioRobotics : AUA 2024 Investor Presentation	03.05.
PROCEPT BioRobotics : 2024 AUA Investor Day	03.05.
PROCEPT BioRobotics : Q1 2024 Procept BioRobotics Earnings Conference Call	02.05.
PROCEPT BioRobotics : Investor Presentation – May 2024	02.05.
Procept BioRobotics Shares Rise After Q1 Loss Narrows, Revenue Increases; 2024 Revenue Guidance Revised	01.05.
PROCEPT BioRobotics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	01.05.
Earnings Flash (PRCT) PROCEPT BIOROBOTICS Reports Q1 Revenue $44.5M, vs. Street Est of $41.7M	01.05.
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance	01.05.
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance	01.05.
Procept Biorobotics Corporation Increases Revenue Guidance for Full Year 2024	01.05.
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia	29.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PROCEPT BioRobotics Corporation

Aktien

A3C3AJ

US74276L1052

PRCT

Andere Sprachen

Filter